(Q39600857)

13 September 2017

title

Antiapoptotic effects of GLP-1 in murine HL-1 cardiomyocytes (English)

1 reference

13 September 2017

1

1 reference

13 September 2017

Amaia Zudaire

2

1 reference

13 September 2017

Richard D Carr

series ordinal

3

1 reference

13 September 2017

Javier Díez

series ordinal

4

1 reference

13 September 2017

publication date

28 January 2011

1 reference

American Journal of Physiology Heart and Circulatory Physiology

13 September 2017

published in

1 reference

13 September 2017

volume

300

1 reference

13 September 2017

issue

4

1 reference

13 September 2017

page(s)

H1361-72

1 reference

Bcl-2 independence of flavopiridol-induced apoptosis. Mitochondrial depolarization in the absence of cytochrome c release.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

21 January 2018

Diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Biology of incretins: GLP-1 and GIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Targeting apoptosis in the heart of streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Anti-proliferative effect of pro-inflammatory cytokines in cultured beta cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide -1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

A novel mouse model of lipotoxic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Glucagon-like peptide-1 agonists protect pancreatic beta-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Mitochondrial pruning by Nix and BNip3: an essential function for cardiac-expressed death factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

cAMP-dependent protein kinase and Ca2+ influx through L-type voltage-gated calcium channels mediate Raf-independent activation of extracellular regulated kinase in response to glucagon-like peptide-1 in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Effect of GLP-1 on glucose transport and its cell signalling in human myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Comparison of the glucose dependency of glucagon-like peptide-1 (7-37) and glyburide in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

A quantitative analysis of kinase inhibitor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Vitamin B1 analog benfotiamine prevents diabetes-induced diastolic dysfunction and heart failure through Akt/Pim-1-mediated survival pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Apoptosis in patients with dilated cardiomyopathy and diabetes: a feature of diabetic cardiomyopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Role of apoptosis in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Neuroprotection of geniposide against hydrogen peroxide induced PC12 cells injury: involvement of PI3 kinase signal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Association of HSPB2, a member of the small heat shock protein family, with mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Apoptosis and the systolic dysfunction in congestive heart failure. Story of apoptosis interruptus and zombie myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart failure-prone rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Mutated recombinant human glucagon-like peptide-1 protects SH-SY5Y cells from apoptosis induced by amyloid-beta peptide (1-42).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Bnip3 mediates permeabilization of mitochondria and release of cytochrome c via a novel mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Cardiac resynchronization therapy-induced left ventricular reverse remodelling is associated with reduced plasma annexin A5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Postmitochondrial regulation of apoptosis during heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Anti-apoptotic action of exendin-4 in INS-1 beta cells: comparative protein pattern analysis of isolated mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Effect of increased expression of cytoskeletal protein vinculin on ischemia-reperfusion injury in ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

Palmitate-mediated Alterations in the Fatty Acid Metabolism of Rat Neonatal Cardiac Myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00885.2010

10.1152/AJPHEART.00885.2010

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference